Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
What You Should Know:
– Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today released a report revealing how Big Pharma is accelerating investment in AI to counter…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Jodie Gillon, CEO of the Trade Organization at BioCT. Connecticut has great…
Continue Reading
What You Should Know:
– Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care announces the availability of NorstellaLinQ on the Atropos Evidence Network.
– Norstella, one of the largest…
Continue Reading
Former President Donald Trump’s return to the White House is certain to bring about changes across many facets of the healthcare sector — including reproductive care, federal insurance programs and prescription drugs.
Experts interviewed for…
Continue Reading
From left to right: Marissa Plescia, reporter at MedCity News; and Merith Basey, executive director of Patients For Affordable Drugs
After much anticipation and a bevy of (ongoing) lawsuits, the U.S. government is finally beginning…
